Aptorum Group Limited
1.21
-0.12 (-9.02%)
At close: Jan 14, 2025, 3:59 PM
1.26
4.13%
After-hours Jan 14, 2025, 07:56 PM EST
undefined%
Bid 1.21
Market Cap 8.64M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 0.31
PE Ratio (ttm) 3.9
Forward PE n/a
Analyst n/a
Ask 1.3
Volume 165,705
Avg. Volume (20D) 2,337,677
Open 1.31
Previous Close 1.33
Day's Range 1.19 - 1.39
52-Week Range 0.46 - 17.49
Beta undefined

About APM

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphyloc...

Industry Biotechnology
Sector Healthcare
IPO Date Dec 18, 2018
Employees 3
Stock Exchange NASDAQ
Ticker Symbol APM